Current Generation of Discrete Monitors That Measure Glucose Noninvasively Show Promise

​​More than a decade has passed since the first announced development-stage noninvasive glucose monitors created anticipation within the diabetes community. Since then, companies and concepts have come and gone, with a few stalwarts continuing to refine their designs and new companies, some with novel approaches, attracting serious funding and working toward creating marketable products.

All of this activity has led to a current generation of monitors that embody a higher level of design focus and real-world practicality than many of the devices that came before them. As developers continue to test and refine, the feeling of many observers has moved away from skepticism to cautious optimism.

To be sure there are risks and issues that remain. Price points and reimbursement levels will be the key to consumer uptake of any noninvasive monitor that receives marketing authorization. There is also the issue of patient-to-patient variability across the general diabetic population. It now appears that by the end of the decade up to five noninvasive monitors could be on the market, putting pressure on margins and marketing budgets. Not to be overlooked, the suppliers of traditional blood sample glucose meters continue to refine their products with features such as microsampling, alternate site testing, wireless connectivity and improved user interfaces, giving current users less reason to consider switching to a higher priced option.

A recent survey of noninvasive glucose monitors is the subject of a new and comprehensive report from Greystone Research Associates. The report – Noninvasive Glucose Monitors to 2022: Devices, Technologies, Players and Prospects - includes assessments of devices and their commercialization prospects, device features, analysis of market factors, profiles of market participants and their activities, and market data and forecasts.

More information is available at

http://www.greystoneassociates.org

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org